Radioisotope concentrator gene therapy using the sodium/iodide symporter gene

Cancer Research

Volumn 59, Issue 3, 1999, Pages 661-668

  Mandell, Robert B ^a,b   Mandell, Leisa Z ^a,b   Link Jr , Charles J ^a  

^a Iowa Cancer Research Foundation   (United States)

^b Molecular Geriatrics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; IODINE 123;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; COLON CARCINOMA; GENE THERAPY; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; TARGET CELL DESTRUCTION; TARGET ORGAN; TISSUE SPECIFICITY;

ADENOCARCINOMA; ANIMALS; CARRIER PROTEINS; COLONIC NEOPLASMS; FEMALE; GENE THERAPY; HUMANS; IODIDES; IODINE RADIOISOTOPES; MELANOMA; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; OVARIAN NEOPLASMS; PERCHLORIC ACID; SYMPORTERS; TECHNETIUM; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033083046     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kasahara, N., Dozy, A., and Kan, Y. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science (Washington DC), 266: 1373-1376, 1994.
2. Batra, R. K., Wang-Johanning, F., Wagner, E., Garver, I., R. I., and Curiel, D. T. Receptor-mediated gene delivery employing leclin-binding specificity. Gene Ther., 1: 255-260, 1994.
3. Miller, N., and Whelan, J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum. Gene Ther., 8, 803-815, 1997.
4. Cooper, M. Noninfectious gene transfer and expression systems for cancer gene therapy. Semin. Oncol., 23: 172-187, 1996.
5. Spitzweg, C., Eisenmenger, W., and Heufelder, A. E. Analysis of the human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J. Clin. Endocrinol. Metab., 83: 1746-1751, 1998.
6. Grigshy, P. W., and Luk, K. H. Thyroid. In: C. A. Perez and L. W. Brady (eds.)., Principles and Practice of Radiation Oncology. Ed 3, pp. 1157-1179. Philadelphia: Lippincott-Raven. 1998.
7. Carrasco, N. Iodide transport in the thyroid gland. Biochem. Biophys. Acta, 1154: 65-82, 1993.
8. Wolff, J. Transport of iodide and other anions in the thyroid gland. Physiol. Rev., 44: 45-90, 1964.
9. Dai, G., Levy, O., and Carrasco, N. Cloning and characterization of the thyroid iodide transporter. Nature (Lond.), 379: 458-460, 1996.
10. +/1-symporters. Biochem. Biophys. Res. Commun., 1996: 94-101, 1996.
11. Smanik, P. A., Liu, Q., Furminger, T. L., Ryu, K., Xing, S., Mazzaferri, E. L., and Jhiung, S. M. Cloning of the human sodium iodide symporter. Biochem. Biophys. Res. Commun., 226, 339-345, 1996.
12. +/1-symporter with an anit-COOH terminus antibody. Proc. Natl. Acad. Sci. USA. 94: 5568-5573, 1997.
13. Hershman, J. M., Blahd, W. H., and Gordon, H. E. The thyroid gland. In: C. M. Haskell (ed.), Cancer Treatment, pp. 743-752. Philadelphia: W. B. Saunders, 1995.
14. Ambesi-Impiombato, F. S., Parks, L. A. M., and Coons, H. G. Culture of hormonedependent epithelial cells from ral thyroids. Proc. Natl. Acad. Sci. USA. 77: 3455-3459, 1980.
15. Miller, A. D., and Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol., 6: 2895-2902, 1986.
16. Link, C J., Moorman, D., Seregina, T., Levy, J. P., and Schabold, K. J. A phase I trial of in vivo gene therapy with the herpes simplex thymidine kinase/ganciclovir system for the treatment of refractory or recurrent ovarian cancer. Hum. Gene Ther., 7: 1161-1179, 1996.
17. Giard, D. J., Aaronson, S. A., Todaro, G. J., Amstein, P., Kersey, J. H., Dosik, H., and Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51: 1417-1423, 1973.
18. Patek, P., Collins, J., and Cohn, M. Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis. Nature (Lond.), 276, 510-511, 1978.
19. Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., and Frost, P. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60: 397-403, 1990.
20. Bernard, J., Da Silva, J., De Blois, M. C., Boyer, P., Duvillard, P., Chiric, E., and Riou, G. Characterization of a human ovarian adenocarcinoma line. IGROVI, in tissue culture and in nude mice. Cancer Res., 45: 4970-4979, 1985.
21. Weiss, S. J., Philp, N. J., and Grollman, E. F. Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology, 114: 1090-1098, 1984.
22. Link, C. J., Evans, M., Cook, J., Stevnsner, T., and Bohr, V. A. Caffeine inhibits preferential repair of UV pyrimidine dimers in hamster and human xeroderma pigmentosum cells. Carcinogenesis (Lond.), 16: 1149-1155, 1995.
23. +/-symporter. Biochem. Biophys. Res. Commun., 231: 731-734, 1997.
24. Lineweaver, H., and Burk, D. The determination of enzyme dissociation constants. J. Am. Chem. Soc., 56: 658-660, 1934.
25. Saha, G. B. Uses of radiopharmaceuticals in nuclear medicine. In: Fundamentals of Nuclear Pharmacy, Ed. 3, pp. 227-304. New York: Springer-Verlag, 1992.
26. Coffin, J. Retroviridae: the viruses and their replication. In: B. Fields, D. Knipe, and P. Howley (eds.)., Fields Virology, pp. 1767-1847. Philadelphia: Lippincott-Raven, 1996.
27. +/I-symporter gene. Endocrinology 138: 4493-4496, 1997.
28. Divgi, C. R. Status of monoclonal antibodies for diagnosis and therapy of cancer. Oncology. 10: 939-953, 1996.
29. Mulshine, J., Magnani, J., and Linnolila, R. Applications of monoclonal antibodies in the treatment of solid tumors. In: J. DeVita, V., S. Hellman, and S. Rosenberg (eds.)., Biologic Therapy of Cancer, pp. 563-588. Philadelphia: Lippincott Company, 1991.
30. Pimm, M., Perkins, A. C., Armitage, N. C., and Baldwin, R. W. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of rudiolabeled monoclonal antibody in cancer patients. J. Nucl. Med., 26: 1011-1023, 1985.
31. Papoian, R. Non-specific immunoglobulin interactions may lead to false-positive results in assays for human anti-mouse monoclonal antibodies (HAMA). J. Immunoassay, 13: 46-49, 1992.
32. Tjandra, J., Ramadi, L., and McKenzie, I. Development of human anti-murine antibody (HAMA) response in patients. Immunol. Cell Biol., 68: 367-376, 1990.
33. Distasio, J., and Cheung, N. Current therapies using monoclonal antibodies. II. Malignant disease. Compr. Ther., 18: 40-44, 1992.
34. Troulfanidis, N. Measurement and detection of radiation., Ed. 2, pp. 265-291. Washington, DC: Taylor and Francis. 1995.
35. Eckerman, K. F. The health physics and radiological handbook, pp. 264-305. Silver Spring: Scinta, Inc., 1992.
36. Courtenay, V D. A replenishable soft agar colony assay for human tumor sensitivity testing. Recent Results Cancer Res., 94: 17-34, 1984.
37. Thomas-Morvan, C., Nataf, B., and Tubiana, M. In vivo and organ culture studies of thyroid proteins and hormone synthesis in human thyroid cancer tissues. Ann. Radiol., 20: 739-742, 1977.
38. Field, J., Larsen, P. R., Yamashita, K., Mashiter, K., and Dekker, A, Demonstration of iodide transport defect but normal iodide organification in nonfunctioning modules of human thyroid glands. J. Clin. Invest., 52: 2404-2410, 1973.
39. Lemarchand-Beraud, T., Valenta, L., and Vannotti, A. Biochemical differences between normal and cancerous thyroid tissues. In: C. E. Hedinger (ed.). Conference on Thyroid Cancer, pp. 205-216, 1969.
40. Saito, T., Endo, T., Kawaguchi, A., Ikeda. M., Katoh, R., Kawaoi, R., Muramatsu, A., and Onaya, T. Increased expression of the sodium/iodide symporte in papillary thyroid carcinomas. J. Clin. Invest., 101: 1296-1300, 1998.
41. Yoshinari, M., Tokuyama, T., Okamura, K., Sato, K., Kusuda, K., and Fujishima, M. Iodide-induced thyrotoxicosis in a thyroidectomized patient with metastatic thyroid carcinoma. Cancer (Phila.), 61: 1674-1678, 1988.
42. Paul, S., and Sisson, J. Thyrotoxicosis caused by thyroid cancer. Endocrinol. Metab. Clin. N. Am., 19: 593-612, 1990.
43. Parker, R., and Withers, R. Principles of radiation oncology. In: C. Haskell (ed.), Cancer Treatment, pp. 23-31. Philadelphia: W. B. Saunders Co., 1995.
44. Roth. J. A., Cristiano, R. J., Roth, J. A., and Cristiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89: 21-39, 1997.